Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Naganuma A, Kosaka H, Matono T, Shibata H, Aoki T, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Iijima H, Kaibori M, Hiasa Y, Kudo M, Kumada T; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Ohama H, et al. Among authors: koizumi y. Oncology. 2023;101(9):542-552. doi: 10.1159/000530028. Epub 2023 Aug 8. Oncology. 2023. PMID: 37552968 Free article.
Brain metastasis from hepatocellular carcinoma treated with a cyber-knife.
Hiraoka A, Horiike N, Koizumi Y, Tazuya N, Ichiryu M, Nakahara H, Ochi H, Tanabe A, Doi H, Kodama A, Hasebe A, Ichikawa S, Miyamoto Y, Ninomiya T, Asagi A, Matsubara H, Nadano S, Nishizaki O, Umeda M. Hiraoka A, et al. Among authors: koizumi y. Intern Med. 2008;47(22):1993-6. doi: 10.2169/internalmedicine.47.1373. Epub 2008 Nov 17. Intern Med. 2008. PMID: 19015615 Free article.
Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications.
Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, Hasebe A, Ichikawa S, Yano M, Miyamoto Y, Ninomiya T, Otomi Y, Kokame M, Iwamura T, Ishimaru Y, Sogabe I, Kashihara K, Nishiura S, Ootani H, Takamura K, Kawasaki H. Hiraoka A, et al. Among authors: koizumi y. Hepatogastroenterology. 2008 Nov-Dec;55(88):2171-4. Hepatogastroenterology. 2008. PMID: 19260499
Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi H, Yamamoto Y, Ichikawa S, Hasebe A, Yano M, Miyamoto Y, Ninomiya T, Ootani H, Takamura K, Kawasaki H, Otomi Y, Kogame M, Sogabe I, Ishimaru Y, Kashihara K, Miyagawa M, Hirooka M, Hiasa Y, Matsuura B, Michitaka K, Onji M. Hiraoka A, et al. Among authors: koizumi y. Hepatogastroenterology. 2009 Jan-Feb;56(89):213-7. Hepatogastroenterology. 2009. PMID: 19453060
Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.
Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Sogabe I, Ishimaru Y, Kawasaki H, Koizumi Y, Hirooka M, Yamashita Y, Abe M, Hiasa Y, Matsuura B, Onji M. Hiraoka A, et al. Among authors: koizumi y. J Gastroenterol Hepatol. 2010 Feb;25(2):403-7. doi: 10.1111/j.1440-1746.2009.06037.x. Epub 2009 Nov 19. J Gastroenterol Hepatol. 2010. PMID: 19929922
716 results